The beneficial effects of Traditional Chinese Medicine on diabetic retinopathy: mechanisms, therapeutics, and prospects

Abstract

Diabetic retinopathy (DR) is a common microvascular sequela of diabetes mellitus. Chronic hyperglycemia contributes to progressive retinal microvascular damage, thereby increasing the risk of visual impairment and irreversible blindness. Traditional Chinese Medicine (TCM) has historically been effective against diabetes and related diseases such as retinopathy. It treats DR based on syndrome differentiation, with individualized regimens tailored to patients’ specific conditions and physical constitutions. This review discusses the pathogenesis of DR in modern medicine and TCM. It also summarizes four therapies for DR, including formulas, Chinese herbs, active components, and acupuncture. We systematically gathered and arranged the pertinent literature on DR from various databases, including PubMed, Web of Science, and ScienceDirect. We analyzed and summarized research advances in TCM for the treatment of DR. Moreover, the GSE60436 dataset was chosen to dissect the variations in gene expression and signaling pathways connected to DR, employing Gene Ontology (GO) enrichment analysis and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway database. Bioinformatics studies have indicated a potential link between the development of DR and the phosphatidylinositol 3-kinases-protein kinase B (PI3K-Akt) and advanced glycation end products (AGE)-receptors for advanced glycation end products (RAGE) pathways. At the same time, we emphasized the cutting-edge targets and strategies for DR treatment interventions. TCM exhibits a distinctive therapeutic efficacy in preventing and treating ocular conditions and mitigating DR via various mechanisms and routes. According to the principle of holistic treatment based on syndrome differentiation in TCM, choosing appropriate TCM treatments has the advantage of improving the clinical efficacy and mitigating adverse effects of Western medications.

Keywords

Diabetic retinopathy / Pathogenesis / PI3K / Traditional Chinese Medicine

References

[1] Wilkinson CP, Ferris FL 3rd, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003; 110(9): 1677-1682.

[2] Li H, Liu X, Zhong H, et al. Research progress on the pathogenesis of diabetic retinopathy. BMC Ophthalmol 2023; 23(1): 372.

[3] Tan Y, Fukutomi A, Sun MT, et al. Anti—VEGF crunch syndrome in proliferative diabetic retinopathy: a review. Surv Ophthalmol 2021; 66(6): 926-932.

[4] Leasher JL, Bourne RR, Flaxman SR, et al. Global estimates on the number of people blind or visually impaired by diabetic retinopathy: a meta—analysis from 1990 to 2010. Diabetes Care 2016; 39(9): 1643-1649.

[5] Singh RS, Covert DJ, Henry CR, et al. Retinal complications associated with pars plana vitrectomy for macular holes or epiretinal membranes in eyes with previous retinal detachment repair. JAMA Ophthalmol 2014; 132(1): 118-119.

[6] Thompson JT. Advantages and limitations of small gauge vitrectomy. Surv Ophthalmol 2011; 56(2): 162-172.

[7] Wen S, Zhang H, Huang X, et al. The therapeutic effect and mechanism of traditional Chinese medicine in type 2 diabetes mellitus and its complications. Diabetes Metab Syndr Obes 2025; 18: 1599-1627.

[8] Singh S, Kushwaha P, Gupta SK. Exploring the potential of traditional herbs in the management of diabetic retinopathy: an overview. Drug Res (Stuttg) 2020; 70(7): 298-309.

[9] Bianco L, Arrigo A, Aragona E, et al. Neuroinflammation and neurodegeneration in diabetic retinopathy. Front Aging Neurosci 2022; 14: 937999.

[10] Guzman DC, Olguín HJ, García EH, et al. Mechanisms involved in the development of diabetic retinopathy induced by oxidative stress. Redox Rep 2017; 22(1): 10-16.

[11] He W, Tang P, Lv H. Targeting oxidative stress in diabetic retinopathy: mechanisms, pathology, and novel treatment approaches. Front Immunol 2025; 16: 1571576.

[12] Gao J, Zheng Z, Gu Q, et al. Deacetylation of MnSOD by PARP—regulated SIRT3 protects retinal capillary endothelial cells from hyperglycemia—induced damage. Biochem Biophys Res Commun 2016; 472(3): 425-431.

[13] Klaassen I, de Vries EW, Vogels IMC, et al. Identification of proteins associated with clinical and pathological features of proliferative diabetic retinopathy in vitreous and fibrovascular membranes. PLoS One 2017; 12(11): e0187304.

[14] Dharmarajan S, Carrillo C, Qi Z, et al. Retinal inflammation in murine models of type 1 and type 2 diabetes with diabetic retinopathy. Diabetologia 2023; 66(11): 2170-2185.

[15] Lim RR, Thomas A, Ramasubramanian A, et al. Retinal microglia—derived S100A9 incite NLRP3 inflammasome in a Western diet fed Ossabaw pig retina. bioRxiv 2024; 621160.

[16] Chu AJ. Tissue factor, blood coagulation, and beyond: an overview. Int J Inflam 2011; 2011(1): 367284.

[17] Murugeswari P, Shukla D, Rajendran A, et al. Proinflammatory cytokines and angiogenic and anti—angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and Eales’ disease. Retina 2008; 28(6): 817-824.

[18] Wan W, Long Y, Jin X, et al. Protective role of microRNA—200a in diabetic retinopathy through downregulation of PDLIM1. J Inflamm Res 2021; 14: 2411-2424.

[19] Forrester JV, Kuffova L, Delibegovic M. The role of inflammation in diabetic retinopathy. Front Immunol 2020; 11: 583687.

[20] Bikbova G, Oshitari T, Bikbov M. Diabetic neuropathy of the retina and inflammation: perspectives. Int J Mol Sci 2023; 24(11): 9166.

[21] Gariano RF, Gardner TW. Retinal angiogenesis in development and disease. Nature 2005; 438(7070): 960-966.

[22] Xu H, Chen M. Diabetic retinopathy and dysregulated innate immunity. Vision Res 2017; 139: 39-46.

[23] Graves DT, Kayal RA. Diabetic complications and dysregulated innate immunity. Front Biosci 2008; 13(4): 1227-1239.

[24] Frantz S, Vincent KA, Feron O, et al. Innate immunity and angiogenesis. Circ Res 2005; 96(1): 15-26.

[25] Ising C, Heneka MT. Functional and structural damage of neurons by innate immune mechanisms during neurodegeneration. Cell Death Dis 2018; 9(2): 120.

[26] Du Y, Smith MA, Miller CM, et al. Diabetes—induced nitrative stress in the retina, and correction by aminoguanidine. J Neurochem 2002; 80(5): 771-779.

[27] Rangasamy S, McGuire PG, Das A. Diabetic retinopathy and inflammation: novel therapeutic targets. Middle East Afr J Ophthalmol 2012; 19(1): 52-59.

[28] Canataroglu H, Varinli I, Ozcan AA, et al. Interleukin (IL)—6, interleukin (IL)—8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy. Ocul Immunol Inflamm 2005; 13(5): 375-381.

[29] Zhang X, Fu Y, Li H, et al. H3 relaxin inhibits the collagen synthesis via ROS— and P2X7R—mediated NLRP3 inflammasome activation in cardiac fibroblasts under high glucose . J Cell Mol Med 2018; 22(3): 1816-1825.

[30] Kong X, Lu AL, Yao XM, et al. Activation of nlrp3 inflammasome by advanced glycation end products promotes pancreatic islet damage. Oxid Med Cell Longev 2017; 2017(1): 9692546.

[31] Zou W, Luo S, Zhang Z, et al. ASK1/p38—mediated NLRP3 inflammasome signaling pathway contributes to aberrant retinal angiogenesis in diabetic retinopathy. Int J Mol Med 2021; 47(2): 732-740.

[32] Chen W, Zhao M, Zhao S, et al. Activation of the TXNIP/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: a novel inhibitory effect of minocycline. Inflamm Res 2017; 66(2): 157-166.

[33] Chai G, Liu S, Yang H, et al. NLRP3 blockade suppresses pro—inflammatory and pro—angiogenic cytokine secretion in diabetic retinopathy. Diabetes Metab Syndr Obes 2020; 13: 3047-3058.

[34] Geng P, Ding Y, Qiu L, et al. Serum mannose—binding lectin is a strong biomarker of diabetic retinopathy in Chinese patients with diabetes. Diabetes Care 2015; 38(5): 868-875.

[35] Shahulhameed S, Vishwakarma S, Chhablani J, et al. A systematic investigation on complement pathway activation in diabetic retinopathy. Front Immunol 2020; 11: 154.

[36] Sacks SH. Complement fragments C3a and C5a: the salt and pepper of the immune response. Eur J Immunol 2010; 40(3): 668-670.

[37] Mazzeo A, Beltramo E, Lopatina T, et al. Molecular and functional characterization of circulating extracellular vesicles from diabetic patients with and without retinopathy and healthy subjects. Exp Eye Res 2018; 176: 69-77.

[38] Huang C, Fisher KP, Hammer SS, et al. Extracellular vesicle—induced classical complement activation leads to retinal endothelial cell damage via MAC deposition . Int J Mol Sci 2020; 21(5): 1693.

[39] Zhu L, Zang J, Liu B, et al. Oxidative stress—induced RAC autophagy can improve the HUVEC functions by releasing exosomes. J Cell Physiol 2020; 235(10): 7392-7409.

[40] Liu Y, Yang Q, Fu H, et al. Müller glia—derived exosomal miR—9—3p promotes angiogenesis by restricting sphingosine—1—phosphate receptor S1P(1) in diabetic retinopathy. Mol Ther Nucleic Acids 2022; 27: 491-504.

[41] Chen T, Wang F, Wei J, et al. Extracellular vesicles derived from different sources play various roles in diabetic retinopathy. Front Endocrinol (Lausanne) 2022; 13: 1064415.

[42] Chen Y, Yao G, Tong J, et al. MSC—derived small extracellular vesicles alleviate diabetic retinopathy by delivering miR—22—3p to inhibit NLRP3 inflammasome activation. Stem Cells 2024; 42(1): 64-75.

[43] Gu C, Zhang H, Gao Y. Adipose mesenchymal stem cells—secreted extracellular vesicles containing microRNA—192 delays diabetic retinopathy by targeting ITGA1. J Cell Physiol 2021; 236(7): 5036-5051.

[44] Zhang X, Shi E, Yang L, et al. LncRNA AK077216 is downregulated in diabetic retinopathy and inhibited the apoptosis of retinal pigment epithelial cells by downregulating miR—383. Endocr J 2019; 66(11): 1011-1016.

[45] Jiang L, Wang C, Shen X. LncRNA GAS5 suppresses ER stress—induced apoptosis and inflammation by regulating SERCA2b in HG—treated retinal epithelial cell. Mol Med Rep 2020; 22(2): 1072-1080.

[46] Ola MS, Alhomida AS, LaNoue KF. Gabapentin attenuates oxidative stress and apoptosis in the diabetic rat retina. Neurotox Res 2019; 36(1): 81-90.

[47] Liu XY, Zheng HW, Wang FZ, et al. Developments in the study of Chinese herbal medicine’s assessment index and action mechanism for diabetes mellitus. Animal Model Exp Med 2024; 7(4): 433-443.

[48] Li Z, Hu F, Xiong L, et al. Underlying mechanisms of traditional Chinese medicine in the prevention and treatment of diabetic retinopathy: evidences from molecular and clinical studies. J Ethnopharmacol 2024; 335: 118641.

[49] Wu P, Ye L, Shao Y, et al. Zhibai Dihuang decoction inhibits oxidative stress induced by “Hyperactivity of Fire Due to Yin Deficiency Syndrome” through ARE Pathway. J Zhejiang Chin Med Univ 2020; 44(4): 316-323.

[50] Gao D, Zhao Y, Sun Y, et al. Effects of Sangpi Drink on sensory threshold of nerve vibration and expression of serum IGF—1 and TNF—α of diabetic peripheral neuropathy (Yin Deficiency and Dryness Heat Syndrome) patients. Acta Chinese Medicine 2022; 37(9): 1971-1976.

[51] Li P, Zhang F, Zhang W, et al. Effect of compound Danshen dropping pills in Qi stagnation and blood stasis syndrome of stable angina pectoris and its influence on the serum ET—1, NO and hs—CRP levels. Clin Med Res Pract 2020; 5(36): 148-50 + 56.

[52] Song ZG, Liu YS, Dai SS, et al. The integration strategy of Didang decoction against cerebral ischemia—reperfusion injury: regulation of apoptosis—autophagy—inflammation network and validation of PI3K/Akt pathway. J Ethnopharmacol 2025; 353(Pt A): 120277.

[53] Xu ZH, Gao YY, Zhang HT, et al. Progress in experimental and clinical research of the diabetic retinopathy treatment using traditional Chinese medicine. Am J Chin Med 2018; 46(7): 1421-1447.

[54] Zhao C, Ma G, Tao S, et al. Qi—Ju—Di—Huang—Pill delays the progression of diabetic retinopathy. J Ethnopharmacol 2024; 333: 118449.

[55] Zhang S, Wu J, Wang L, et al. SIRT1/P53 in retinal pigment epithelial cells in diabetic retinopathy: a gene co—expression analysis and He—Ying—Qing—Re formula treatment. Front Mol Biosci 2024; 11: 1366020.

[56] Zhang C, Xu Y, Tan HY, et al. Neuroprotective effect of He—Ying—Qing—Re formula on retinal ganglion cell in diabetic retinopathy. J Ethnopharmacol 2018; 214: 179-189.

[57] Huang DL, Wang SW, Gao Y, et al. Yi—qi—yang—yin decoction ameliorates diabetic retinopathy: New and comprehensive evidence from network pharmacology, machine learning, molecular docking and molecular biology experiment. J Pharm Biomed Anal 2025: 260116794.

[58] Lee YM, Lee YR, Kim CS, et al. Effect of Guibi—Tang, a traditional herbal formula, on retinal neovascularization in a mouse model of proliferative retinopathy. Int J Mol Sci 2015; 16(12): 29900-29910.

[59] Lei X, He J, Ren C, et al. Protective effects of the Chinese herbal medicine prescription Zhujing pill on retina of streptozotocin—induced diabetic rats. Biomed Pharmacother 2018; 98: 643-650.

[60] Ye X, Ren H, Jiang T, et al. Effect of diabetes blood—stasis syndrome and Xuefu Zhuyu decoction on ROS—ERK1/2 signaling pathway in rat retina Müller cells. Cytotechnology 2020; 72(2): 303-314.

[61] Chen W, Yao X, Zhou C, et al. Danhong Huayu Koufuye prevents diabetic retinopathy in streptozotocin—induced diabetic rats via antioxidation and anti—inflammation . Mediators Inflamm 2017; 2017(1): 3059763.

[62] Lee YM, Kim CS, Sohn E, et al. Sipjeondaebo—tang, a traditional herbal formula, inhibits retinal neovascularization in a mouse model of oxygen—induced retinopathy. Tohoku J Exp Med 2014; 234(3): 229-236.

[63] Ge X, Huang C, Chen W, et al. Effect of Danggui Buxue decoction on hypoxia—induced injury of retinal Müller cells in vitro. Eur J Histochem 2024; 68(4): 4140.

[64] Wang X, Li Y, Xie M, et al. Urine metabolomics study of Bushen Huoxue prescription on diabetic retinopathy rats by UPLC—Q—exactive Orbitrap—MS. Biomed Chromatogr 2020; 34(4): e4792.

[65] Luo XX, Duan JG, Liao PZ, et al. Effect of qiming granule on retinal blood circulation of diabetic retinopathy: a multicenter clinical trial. Chin J Integr Med 2009; 15(5): 384-388.

[66] Wei G, Gao P. Clinical observation on Zhenwu decoction for treatment of elderly type 2 diabetic retinopathy. Chin J Exp Tradit Med Formulae 2012; 18(21): 311-313.

[67] Zhao Y, Yu J, Liu J, et al. The role of liuwei dihuang pills and ginkgo leaf tablets in treating diabetic complications. Evid Based Complement Alternat Med 2016; 2016(1): 7931314.

[68] Yong—he H, Shen—tao W, Jing L. Treatment of diabetic retinopathy with acupuncture plus herbal decoction: clinical observation of 40 cases. J Acupunct Tuina Sci 2004; 2(6): 29-31. In Chinese.

[69] Ye C, Zhang Y. Clinical observation of harmonlzing Ying and clearing heat therapy on diabetic retinopathy in non—proliferative stage. Hebei J Tradit Chin Med 2012; 34(8): 1204-1205. In Chinese.

[70] Jin W, Liu A. Clinical research of Jiawei buyang huanwu decoction on treatment of nonproliferative diabetic retinopathy. J Tradit Chin Ophthalmol 2008; 18(5): 270-272. In Chinese.

[71] Lian F, Wu L, Tian J, et al. The effectiveness and safety of a danshen—containing Chinese herbal medicine for diabetic retinopathy: a randomized, double—blind, placebo—controlled multicenter clinical trial. J Ethnopharmacol 2015; 164: 71-77.

[72] Jin D, Zhang Y, Zhang Y, et al. Efficacy and safety of tangwang prescription for type 2 non—proliferative diabetic retinopathy: a study protocol for a randomized controlled trial. Front Pharmacol 2021; 12: 594308.

[73] Lei X, Zhou Y, Ren C, et al. Typhae pollen polysaccharides ameliorate diabetic retinal injury in a streptozotocin—induced diabetic rat model. J Ethnopharmacol 2018; 224: 169-176.

[74] Chen T, Chen C, Huang Y, et al. Ethanolic extract of Puhuang (Pollen Typhae) modulates lipopolysaccharide—induced inflammatory response through inducible nitric oxide synthase/cyclooxygenase—2 signaling in RAW 264.7 macrophage. J Tradit Chin Med 2021; 41(6): 836-844.

[75] Chen MT, Huang RL, Ou LJ, et al. Pollen typhae total flavone inhibits endoplasmic reticulum stress—induced apoptosis in human aortic—vascular smooth muscle cells through down—regulating PERK—eIF2α—ATF4—CHOP pathway. Chin J Integr Med 2019; 25(8): 604-612.

[76] Feng XT, Chen Q, Xie Z, et al. Pollen Typhae total flavone improves insulin resistance in high—fat diet and low—dose streptozotocin—induced type 2 diabetic rats. Biosci Biotechnol Biochem 2014; 78(10): 1738-1742.

[77] Zhou R, Jin D, Zhang Y, et al. Investigating the mechanisms of pollen typhae in the treatment of diabetic retinopathy based on network pharmacology and molecular docking. Evid Based Complement Alternat Med 2022; 2022(1): 5728408.

[78] Hsu WH, Sangkhathat C, Lu MK, et al. Dendrobium nobile polysaccharide attenuates blue light—induced injury in retinal cells and in vivo in drosophila. Antioxidants (Basel) 2024; 13(5): 603.

[79] Yang CC, Chien JY, Chou YY, et al. The effects of lycium chinense, cuscuta chinensis, senna tora, ophiopogon japonicus, and dendrobium Nobile decoction on a dry eye mouse model. Medicina (Kaunas) 2022; 58(8): 1134.

[80] Chen W, Lu J, Zhang J, et al. Traditional uses, phytochemistry, pharmacology, and quality control of dendrobium officinale Kimura et. Migo. Front Pharmacol 2021; 12: 726528.

[81] Liu JJ, Liu ZP, Zhang XF, et al. Effects of various processing methods on the metabolic profile and antioxidant activity of dendrobium catenatum Lindley leaves. Metabolites 2021; 11(6): 351.

[82] Gong CY, Yu ZY, Lu B, et al. Ethanol extract of Dendrobium chrysotoxum Lindl ameliorates diabetic retinopathy and its mechanism. Vascul Pharmacol 2014; 62(3): 134-142.

[83] Yu Z, Zhang T, Gong C, et al. Erianin inhibits high glucose—induced retinal angiogenesis via blocking ERK1/2—regulated HIF—1α—VEGF/VEGFR2 signaling pathway . Sci Rep 2016; 6: 34306.

[84] Yu Z, Gong C, Lu B, et al. Dendrobium chrysotoxum Lindl. alleviates diabetic retinopathy by preventing retinal inflammation and tight junction protein decrease. J Diabetes Res 2015; 2015(1): 518317.

[85] Li S, Hu X, Liu F, et al. Bioactive components and clinical potential of Astragalus species. Front Pharmacol 2025; 16: 1585697.

[86] Jin Q, Hao XF, Xie LK, et al. A network pharmacology to explore the mechanism of astragalus membranaceus in the treatment of diabetic retinopathy. Evid Based Complement Alternat Med 2020; 2020(1): 8878569.

[87] Ke M, Hu XQ, Ouyang J, et al. The effect of astragalin on the VEGF production of cultured Müller cells under high glucose conditions. BioMed Mater Eng 2012; 22(1—3): 113-119.

[88] Cheng L, Zhang G, Zhou Y, et al. Systematic review and meta—analysis of 16 randomized clinical trials of radix astragali and its prescriptions for diabetic retinopathy. Evid Based Complement Alternat Med 2013; 2013(1): 762783.

[89] Hong TY, Tzeng TF, Liou SS, et al. The ethanol extract of Zingiber zerumbet rhizomes mitigates vascular lesions in the diabetic retina. Vascul Pharmacol 2016; 76: 18-27.

[90] Mei XY, Zhou LY, Zhang TY, et al. Scutellaria barbata attenuates diabetic retinopathy by preventing retinal inflammation and the decreased expression of tight junction protein. Int J Ophthalmol 2017; 10(6): 870-877.

[91] Sohn E, Kim J, Kim CS, et al. Extract of polygonum cuspidatum attenuates diabetic retinopathy by inhibiting the High—Mobility Group Box—1 (HMGB1) signaling pathway in streptozotocin—induced diabetic rats. Nutrients 2016; 8(3): 140.

[92] Zhou L, Zhang T, Lu B, et al. Lonicerae Japonicae Flos attenuates diabetic retinopathy by inhibiting retinal angiogenesis. J Ethnopharmacol 2016; 189: 117-125.

[93] Zhang H, Gao Y, Zhang J, et al. The effect of total lignans from Fructus Arctii on Streptozotocin—induced diabetic retinopathy in Wistar rats. J Ethnopharmacol 2020; 255: 112773.

[94] Singh B, Semwal BC. A compressive review on source, toxicity and biological activity of flavonoid. Curr Top Med Chem 2024; 24(24): 2093-2116.

[95] Fu Y, Jia Y, Sun Y, et al. Dietary flavonoids alleviate inflammation and vascular endothelial barrier dysfunction induced by advanced glycation end products in vitro. Nutrients 2022; 14(5): 1026.

[96] Mirza MA, Mahmood S, Hilles AR, et al. Quercetin as a therapeutic product: evaluation of its pharmacological action and clinical applications—a review. Pharmaceuticals (Basel) 2023; 16(11): 1631.

[97] Chen Y, Li XX, Xing NZ, et al. Quercetin inhibits choroidal and retinal angiogenesis in vitro. Graefes Arch Clin Exp Ophthalmol 2008; 246(3): 373-378.

[98] Ola MS, Ahmed MM, Shams S, et al. Neuroprotective effects of quercetin in diabetic rat retina. Saudi J Biol Sci 2017; 24(6): 1186-1194.

[99] Sikorska E, Kasarełło K, Dziedziak J, et al. Neurotrophins of the retina and their involvement in early—stage diabetic retinopathy in an animal model of type 1 diabetes mellitus. Eur J Ophthalmol 2025; 35(6): 2163-2173.

[100] Saikia L, Barbhuiya SAA, Saikia K, et al. Therapeutic potential of quercetin in diabetic neuropathy and retinopathy: exploring molecular mechanisms. Curr Top Med Chem 2024; 24(27): 2351-2361.

[101] De Nicoló S, Tarani L, Ceccanti M, et al. Effects of olive polyphenols administration on nerve growth factor and brain—derived neurotrophic factor in the mouse brain. Nutrition 2013; 29(4): 681-687.

[102] Park H, Poo MM. Neurotrophin regulation of neural circuit development and function. Nat Rev Neurosci 2013; 14(1): 7-23.

[103] Kumar B, Gupta SK, Nag TC, et al. Retinal neuroprotective effects of quercetin in streptozotocin—induced diabetic rats. Exp Eye Res 2014; 125: 193-202.

[104] Zhou YX, Zhang H, Peng C. Puerarin:A review of pharmacological effects. Phytother Res 2014; 28(7): 961-975.

[105] Chen X, Yu J, Shi J. Management of diabetes mellitus with puerarin, a natural isoflavone from pueraria lobata. Am J Chin Med 2018; 46(8): 1771-1789.

[106] Teng Y, Cui H, Yang M, et al. Protective effect of puerarin on diabetic retinopathy in rats. Mol Biol Rep 2009; 36(5): 1129-1133.

[107] Uçar K, Göktaş Z. Biological activities of naringenin: a narrative review based on in vitro and in vivo studies. Nutr Res 2023; 119: 43-55.

[108] Al—Dosari DI, Ahmed MM, Al—Rejaie SS, et al. Flavonoid naringenin attenuates oxidative stress, apoptosis and improves neurotrophic effects in the diabetic rat retina. Nutrients 2017; 9(10): 1161.

[109] Xue B, Wang Y. Naringenin upregulates GTPCH1/eNOS to ameliorate high glucose—induced retinal endothelial cell injury. Exp Ther Med 2022; 23(6): 428.

[110] Čulenová M, Sychrová A, Hassan STS, et al. Multiple in vitro biological effects of phenolic compounds from Morus alba root bark. J Ethnopharmacol 2020; 248: 112296.

[111] Wei X, Zhou J, Zeng L, et al. Highly oxygenated dihydrostilbenoids and flavones from the aerial part of Glycyrrhiza uralensis and their antimicrobial activities. Sci Tradit Chin Med 2024; 2(4): 291-302.

[112] Urošević M, Nikolić L, Gajić I, et al. Curcumin: biological activities and modern pharmaceutical forms. Antibiotics (Basel) 2022; 11(2): 135.

[113] Xie T, Chen X, Chen W, et al. Curcumin is a potential adjuvant to alleviates diabetic retinal injury via reducing oxidative stress and maintaining nrf2 pathway homeostasis . Front Pharmacol 2021; 12: 796565.

[114] Yao B, Xin ZK, Wang D. The effect of curcumin on intravitreal proinflammatory cytokines, oxidative stress markers, and vascular endothelial growth factor in an experimental model of diabetic retinopathy. J Physiol Pharmacol 2023; 74(6): 667-676.

[115] Yang F, Yu J, Ke F, et al. Curcumin alleviates diabetic retinopathy in experimental diabetic rats. Ophthalmic Res 2018; 60(1): 43-54.

[116] Ahmad I, Hoda M. Attenuation of diabetic retinopathy and neuropathy by resveratrol: review on its molecular mechanisms of action. Life Sci 2020; 245: 117350.

[117] Soufi FG, Mohammad—Nejad D, Ahmadieh H. Resveratrol improves diabetic retinopathy possibly through oxidative stress—nuclear factor κB—apoptosis pathway. Pharmacol Rep 2012; 64(6): 1505-1514.

[118] Chen Y, Meng J, Li H, et al. Resveratrol exhibits an effect on attenuating retina inflammatory condition and damage of diabetic retinopathy via PON1 . Exp Eye Res 2019; 181: 356-366.

[119] Yang D, So KF, Lo AC. Lycium barbarum polysaccharide extracts preserve retinal function and attenuate inner retinal neuronal damage in a mouse model of transient retinal ischaemia. Clin Exp Ophthalmol 2017; 45(7): 717-729.

[120] Wang Y, Lan C, Liao X, et al. Polygonatum sibiricum polysaccharide potentially attenuates diabetic retinal injury in a diabetic rat model. J Diabetes Investig 2019; 10(4): 915-924.

[121] Hua J, Guerin KI, Chen J, et al. Resveratrol inhibits pathologic retinal neovascularization in Vldlr(—/—) mice. Invest Ophthalmol Vis Sci 2011; 52(5): 2809-2816.

[122] Li WL, Li K, Chang WG, et al. 20(R)—ginsenoside Rg3 alleviates diabetic retinal injury in T2DM mice by attenuating ROS—mediated ER stress through the activation of the Nrf2/HO—1 axis. Phytomedicine 2024; 135: 156202.

[123] Dong C, Liu P, Wang H, et al. Ginsenoside Rb1 attenuates diabetic retinopathy in streptozotocin—induced diabetic rats1. Acta Cir Bras 2019; 34(2): e201900201.

[124] Gao Y, Ji Y, Luo Y, et al. Ginsenoside Rg1 prevents early diabetic retinopathy via reducing retinal ganglion cell layer and inner nuclear layer cell apoptosis in db/db mice . Ann Transl Med 2020; 8(5): 232.

[125] Maeng YS, Maharjan S, Kim JH, et al. Rk1, a ginsenoside, is a new blocker of vascular leakage acting through actin structure remodeling. PLoS One 2013; 8(7): e68659.

[126] Ding Y, Yuan S, Liu X, et al. Protective effects of astragaloside IV on db/db mice with diabetic retinopathy. PLoS One 2014; 9(11): e112207.

[127] Shi J—H, Hu Y—G, Zhu Y—b, et al. Use of acupuncture in sepsis with gastrointestinal dysfunction: a systematic review and meta—analysis. Sci Tradit Chin Med 2025; 3(3): 282-291.

[128] Zhou Y, Li H, Luo L, et al. Acupoint injection therapy for diabetic retinopathy: a protocol for systematic review and meta—analysis. Medicine (Baltim) 2021; 100(1): e24119.

[129] Feng Y, Fang Y, Wang Y, et al. Acupoint therapy on diabetes mellitus and its common chronic complications: a review of its mechanisms. Biomed Res Int 2018; 2018(1): 3128378.

[130] Zhu BC, Liang YY, Liu J, et al. ZHANG Ren’s experiences in treatment of diabetic retinopathy with acupuncture. Zhongguo Zhen Jiu 2021; 41(6): 659-662.

[131] Ang L, Song E, Jun JH, et al. Acupuncture for treating diabetic retinopathy: a systematic review and meta—analysis of randomized controlled trials. Complement Ther Med 2020; 52: 102490.

[132] Cheng Y, Zhang M, Li C, et al. Endothelial AGGF1 promotes retinal angiogenesis by coordinating TNFSF12/FN14 signalling. Nat Commun 2025; 16(1): 1332.

[133] Tang K, Huang C, Huang Z, et al. GPR30—driven fatty acid oxidation targeted by ginsenoside Rd maintains mitochondrial redox homeostasis to restore vascular barrier in diabetic retinopathy. Cardiovasc Diabetol 2025; 24(1): 121.

[134] Chen X, Wang Y, Wang JN, et al. Lactylation—driven FTO targets CDK2 to aggravate microvascular anomalies in diabetic retinopathy. EMBO Mol Med 2024; 16(2): 294-318.

[135] Shao YQ, Wang YC, Wang L, et al. Topical administration of GLP—1 eyedrops improves retinal ganglion cell function by facilitating presynaptic GABA release in early experimental diabetes. Neural Regen Res 2026; 21(2): 800-810.

[136] Sun Y, Chen S, Qi X, et al. Engineered MEVs for photoreceptor—targeted delivery of USP25 to alleviate diabetic retinopathy. J Nanobiotechnology 2025; 23(1): 575.